Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06714591 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

NCT06714591 · ClinicalTrials.gov record · last posted 2026-07-21

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

Name: Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1 — clinical trial record (NCT06714591)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorSystImmune Inc.

Started2024-12-19

View on ClinicalTrials.gov ↗

from the ClinicalTrials.gov record

The objective of this study to evaluate the safety, tolerability, pharmacokinetic profile, and preliminary efficacy of BL-M11D1 in patients with relapsed/refractory acute myeloid leukemia.

Protocol amendment history 1 change detected by DataLookout

2026-05-28

Trial sites expanded: 14 → 18 locations

Trial Details

NCT Number	NCT06714591
Lead Sponsor	SystImmune Inc.
Conditions	Relapsed/Refractory Acute Myeloid Leukemia
Enrollment	120 participants
Start Date	2024-12-19
Primary Completion	2026-12-31 (estimated)
Study Completion	2027-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-21